Saudi Journal of Gastroenterology
Home About us Instructions Submission Subscribe Advertise Contact Login    Print this page  Email this page Small font sizeDefault font sizeIncrease font size 
Users Online: 446 
This article has been cited by
1Liver steatosis in hepatitis C patients
Emilio González-Reimers
World Journal of Hepatology.2015;7(10)1337
[DOI]
2Structural and Functional Interaction of ?9-Tetrahydrocannabinol with Liver Fatty Acid Binding Protein (FABP1)
Huan Huang,Avery L. McIntosh,Gregory G. Martin,Lawrence J. Dangott,Ann B. Kier,Friedhelm Schroeder
Biochemistry.2018;57(41)6027
[DOI]
3Endocannabinoid receptor blockade reduces alanine aminotransferase in polycystic ovary syndrome independent of weight loss
Alison J. Dawson,Eric S. Kilpatrick,Anne-Marie Coady,Abeer M. M. Elshewehy,Youssra Dakroury,Lina Ahmed,Stephen L. Atkin,Thozhukat Sathyapalan
BMC Endocrine Disorders.2017;17(1)6027
[DOI]
4Role of the endocannabinoid system in vertebrates: Emphasis on the zebrafish model
Francesca Oltrabella,Adam Melgoza,Brian Nguyen,Su Guo
Development, Growth & Differentiation.2017;59(4)194
[DOI]
5Fatty Acid Binding Protein-1 (FABP1) and the Human FABP1 T94A Variant: Roles in the Endocannabinoid System and Dyslipidemias
Friedhelm Schroeder,Avery L. McIntosh,Gregory G. Martin,Huan Huang,Danilo Landrock,Sarah Chung,Kerstin K. Landrock,Lawrence J. Dangott,Shengrong Li,Martin Kaczocha,Eric J. Murphy,Barbara P. Atshaves,Ann B. Kier
Lipids.2016;51(6)655
[DOI]
6Cannabinoid Receptor 1 Gene Polymorphisms and Nonalcoholic Fatty Liver Disease in Women with Polycystic Ovary Syndrome and in Healthy Controls
Justyna Kuliczkowska Plaksej,Lukasz Laczmanski,Andrzej Milewicz,A. Lenarcik-Kabza,Anna Trzmiel-Bira,Urszula Zaleska-Dorobisz,Felicja Lwow,Lidia Hirnle
International Journal of Endocrinology.2014;2014(6)1
[DOI]
7Differential hepatoprotective role of the cannabinoid CB 1 and CB 2 receptors in paracetamol-induced liver injury
Patricia Rivera,Antonio Vargas,Antoni Pastor,Anna Boronat,Antonio Jesús López-Gambero,Laura Sánchez-Marín,Dina Medina-Vera,Antonia Serrano,Francisco Javier Pavón,Rafael Torre,Ekaitz Agirregoitia,María Isabel Lucena,Fernando Rodríguez de Fonseca,Juan Decara,Juan Suárez
British Journal of Pharmacology.2020;177(14)3309
[DOI]
8Cigarette smoke during lactation in rat female progeny: Late effects on endocannabinoid and dopaminergic systems
P.N. Soares,R.A. Miranda,T.C. Peixoto,F.A.H. Caramez,D.S. Guarda,A.C. Manhães,E. de Oliveira,E.G. de Moura,P.C. Lisboa
Life Sciences.2019;232(14)116575
[DOI]
9Scp-2/Scp-x ablation in Fabp1 null mice differentially impacts hepatic endocannabinoid level depending on dietary fat
Gregory G. Martin,Drew R. Seeger,Avery L. McIntosh,Sarah Chung,Sherrelle Milligan,Danilo Landrock,Lawrence J. Dangott,Mikhail Y. Golovko,Eric J. Murphy,Ann B. Kier,Friedhelm Schroeder
Archives of Biochemistry and Biophysics.2018;650(14)93
[DOI]
10The effect of cannabinoid receptor 1 blockade on hepatic free fatty acid profile in mice with nonalcoholic fatty liver disease
Bojan Jorgacevic,Danijela Vucevic,Ivana Ðuricic,Sladana Šobajic,Dušan Mladenovic,Milena Veskovic,Rada Ješic Vukicevic,Tatjana Radosavljevic
Chemistry and Physics of Lipids.2017;204(14)85
[DOI]
11Profiling DNA methylation patterns of zebrafish liver associated with parental high dietary arachidonic acid
Anne-Catrin Adam,Kai Kristoffer Lie,Paul Whatmore,Lars Martin Jakt,Mari Moren,Kaja Helvik Skjærven,Sriharsa Pradhan
PLOS ONE.2019;14(8)e0220934
[DOI]
12Cannabis Consumption Systemic Adverse Effects
Maurizio Coppola,Raffaella Mondola
International Journal of High Risk Behaviors and Addiction.2014;3(2)e0220934
[DOI]
13Impact of Fabp1 Gene Ablation on Uptake and Degradation of Endocannabinoids in Mouse Hepatocytes
Avery L. McIntosh,Huan Huang,Danilo Landrock,Gregory G. Martin,Shengrong Li,Ann B. Kier,Friedhelm Schroeder
Lipids.2018;53(6)561
[DOI]
14Female Mice are Resistant to Fabp1 Gene Ablation-Induced Alterations in Brain Endocannabinoid Levels
Gregory G. Martin,Sarah Chung,Danilo Landrock,Kerstin K. Landrock,Lawrence J. Dangott,Xiaoxue Peng,Martin Kaczocha,Eric J. Murphy,Ann B. Kier,Friedhelm Schroeder
Lipids.2016;51(9)1007
[DOI]
15Loss of fatty acid binding protein-1 alters the hepatic endocannabinoid system response to a high-fat diet
Gregory G. Martin,Danilo Landrock,Sarah Chung,Lawrence J. Dangott,Avery L. McIntosh,John T. Mackie,Ann B. Kier,Friedhelm Schroeder
Journal of Lipid Research.2017;58(11)2114
[DOI]
16Exercise without dietary changes alleviates nonalcoholic fatty liver disease without weight loss benefits
Duck-Pil Ok,Kangeun Ko,Ju Yong Bae
Lipids in Health and Disease.2018;17(1)2114
[DOI]
17The effects of cannabidiol on male reproductive system: A literature review
Renata K. Carvalho,Monica L. Andersen,Renata Mazaro-Costa
Journal of Applied Toxicology.2020;40(1)132
[DOI]
18Plant-derived natural therapeutics targeting cannabinoid receptors in metabolic syndrome and its complications: A review
Ashwani S. Patil,Umesh B. Mahajan,Yogeeta O. Agrawal,Kalpesh R. Patil,Chandragouda R. Patil,Shreesh Ojha,Charu Sharma,Sameer N. Goyal
Biomedicine & Pharmacotherapy.2020;132(1)110889
[DOI]
19Système endocannabinoïde : effets sur le métabolisme glucidique, mais aussi lipidique
A.-L. Sberna,P. Degrace,B. Vergès
Médecine des Maladies Métaboliques.2016;10(5)407
[DOI]
20FABP-1 gene ablation impacts brain endocannabinoid system in male mice
Gregory G. Martin,Sarah Chung,Danilo Landrock,Kerstin K. Landrock,Huan Huang,Lawrence J. Dangott,Xiaoxue Peng,Martin Kaczocha,Drew R. Seeger,Eric J. Murphy,Mikhail Y. Golovko,Ann B. Kier,Friedhelm Schroeder
Journal of Neurochemistry.2016;138(3)407
[DOI]
21Human Liver Fatty Acid Binding Protein-1 T94A Variant, Nonalcohol Fatty Liver Disease, and Hepatic Endocannabinoid System
Gregory G. Martin,Danilo Landrock,Lawrence J. Dangott,Avery L. McIntosh,Ann B. Kier,Friedhelm Schroeder
Lipids.2018;53(1)27
[DOI]
22Endocannabinoid System in Hepatic Glucose Metabolism, Fatty Liver Disease, and Cirrhosis
Ivonne Bazwinsky-Wutschke,Alexander Zipprich,Faramarz Dehghani
International Journal of Molecular Sciences.2019;20(10)2516
[DOI]
23Ontogeny and programming of the fetal temporal cortical endocannabinoid system by moderate maternal nutrient reduction in baboons ( Papio spp.)
Kushal Gandhi,Vanessa Montoya-Uribe,Stacy Martinez,Samuel David,Bobby Jain,Grace Shim,Cun Li,Susan Jenkins,Peter Nathanielsz,Natalia Schlabritz-Loutsevitch
Physiological Reports.2019;7(6)e14024
[DOI]
24?9-Tetrahydrocannabinol induces endocannabinoid accumulation in mouse hepatocytes: antagonism by Fabp1 gene ablation
Avery L. McIntosh,Gregory G. Martin,Huan Huang,Danilo Landrock,Ann B. Kier,Friedhelm Schroeder
Journal of Lipid Research.2018;59(4)646
[DOI]
25FABP1: A Novel Hepatic Endocannabinoid and Cannabinoid Binding Protein
Huan Huang,Avery L. McIntosh,Gregory G. Martin,Danilo Landrock,Sarah Chung,Kerstin K. Landrock,Lawrence J. Dangott,Shengrong Li,Ann B. Kier,Friedhelm Schroeder
Biochemistry.2016;55(37)5243
[DOI]
26Endocannabinoid Interaction with Human FABP1: Impact of the T94A Variant
Gregory G. Martin,Huan Huang,Avery L. McIntosh,Ann B. Kier,Friedhelm Schroeder
Biochemistry.2017;56(38)5147
[DOI]
27Focus on emerging drugs for the treatment of patients with non-alcoholic fatty liver disease
Alessandro Federico
World Journal of Gastroenterology.2014;20(45)16841
[DOI]
  Search 
  The Journal 
  Site Statistics 
  Addresses 
  My Preferences 
  Online Submission 

Submit Articles

Alerts

Join us